| scholarly article | Q13442814 |
| P356 | DOI | 10.1586/ERN.12.92 |
| P698 | PubMed publication ID | 23039383 |
| P50 | author | Changsu Han | Q39541571 |
| P2093 | author name string | Chi-Un Pae | |
| Sheng-Min Wang | |||
| Soo-Jung Lee | |||
| Won-Myong Bahk | |||
| Geun-Young Park | |||
| Seung-Yeop Lee | |||
| P2860 | cites work | Antidepressants and Body Weight | Q22305456 |
| A rating scale for depression | Q24564540 | ||
| Botulinum toxin: examining duration of effect in facial aesthetic applications | Q30980391 | ||
| Aripiprazole as adjunctive therapy for patients with major depressive disorder: overview and implications of clinical trial data | Q33799660 | ||
| Treatment-emergent sexual dysfunction related to antidepressants: a meta-analysis | Q34017507 | ||
| The STAR*D Project results: a comprehensive review of findings. | Q34741960 | ||
| Aripiprazole in the treatment of depressive and anxiety disorders: a review of current evidence | Q37133284 | ||
| The effects of repetitive transcranial magnetic stimulation in the treatment of depression | Q37820978 | ||
| Systematic review and meta-analysis of vagus nerve stimulation in the treatment of depression: variable results based on study designs | Q37964283 | ||
| What did STAR*D teach us? Results from a large-scale, practical, clinical trial for patients with depression | Q43251150 | ||
| Enhancing adherence to prevent depression relapse in primary care | Q44583683 | ||
| Facing depression with botulinum toxin: a randomized controlled trial | Q48723314 | ||
| Pharmacologic denervation of frown muscles enhances baseline expression of happiness and decreases baseline expression of anger, sadness, and fear. | Q51020747 | ||
| Reproducibility of a four-point clinical severity score for glabellar frown lines. | Q52010522 | ||
| P433 | issue | 9 | |
| P304 | page(s) | 1049-1051 | |
| P577 | publication date | 2012-09-01 | |
| P1433 | published in | Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders | Q15760319 |
| P1476 | title | Can botulinum toxin improve mood in depressed patients? | |
| P478 | volume | 12 |
| Q44606020 | Botulinum toxin: the misguided path |
| Q41466581 | Efficacy of Botox versus Placebo for Treatment of Patients with Major Depression |
| Q37034471 | Facial reactions in response to dynamic emotional stimuli in different modalities in patients suffering from schizophrenia: a behavioral and EMG study |
| Q38148244 | Omega-3 polyunsaturated fatty acids for major depressive disorder |
Search more.